Pulmonary Fibrosis: all 685 studies
Page 6 of 7. Open to participants first (120), then studies with results posted, then the rest; newest registration first within each.
- Prednisone in Cystic Fibrosis Pulmonary ExacerbationsCompletedNCT03070522Phase 3
- Accuracy of Spircare Device as Compared to the Conventional PlethysmographStatus unknownNCT03056066
- Short-term Effects of Supplemental Oxygen in Patients With IPFCompletedNCT03050255Not applicable
- Evaluation of Efficacy and Safety of Rituximab With Mycophenolate Mofetil in Patients With Interstitial Lung DiseasesCompletedNCT02990286Phase 3
- Clinical Course of Interstitial Lung Diseases: European IPF Registry and BiobankActive, not recruitingNCT02951416
- Palliative Care in Pulmonary FibrosisCompletedNCT02929966Not applicable
- Integrating Palliative Care for Patients With Idiopathic Pulmonary Fibrosis and Their CaregiversCompletedNCT02929017Not applicable
- Targeting Pro-Inflammatory Cells in Idiopathic Pulmonary Fibrosis: a Human TrialCompletedNCT02874989Phase 1
- The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation PatientsCompletedNCT02859194Not applicable
- Yoga Effect on Quality of Life Study Among Patients with Idiopathic Pulmonary FibrosisActive, not recruitingNCT02848625Not applicable
- Evaluation of Novel Lung Function Parameters in Patients With Interstitial Lung Disease (ILD)Status unknownNCT02827734
- Turkish Thoracic Society Usual Interstitial Pneumonia Registry StudyTerminatedNCT02821039
- Health-related Quality of Life and Comorbidities in Danish Patients With Idiopathic Pulmonary Fibrosis - a Nationwide Follow-upCompletedNCT02818712
- A Clinical Evaluation of Baofeikang Granule in Combined Pulmonary Fibrosis and Emphysema TreatmentStatus unknownNCT02805699Phase 2
- Early Diagnosis of Pulmonary Fibrosis - Diagnostic DelayActive, not recruitingNCT02772549
- Computerized Lung Sound AnalysisCompletedNCT02771184Not applicable
- Pulmonary Fibrosis Foundation Patient RegistryCompletedNCT02758808
- Pulmonary Fibrosis Biomarker Cohort - a Prospective Cohort of Incident Patients With IPFActive, not recruitingNCT02755441
- Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung DisordersTerminatedNCT02748798Early Phase 1
- Clinical Efficacy and Safety of Autologous Lung Stem Cell Transplantation in Patients With Idiopathic Pulmonary FibrosisCompletedNCT02745184Phase 1/2
- Clinical Study of ART-123 for the Treatment of Acute Exacerbation of Idiopathic Pulmonary FibrosisCompletedNCT02739165Phase 3
- Evaluation of Long-Term Safety of Pirfenidone (Esbriet) in Participants With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT02699879
- Effect of Ambulatory Oxygen on the Walking Test in Patients With Pulmonary FibrosisCompletedNCT02668029Phase 2
- A Study of Oral Vismodegib in Combination With Pirfenidone in Participants With Idiopathic Pulmonary FibrosisCompletedNCT02648048Phase 1
- Validation of the Risk Stratification Score in Idiopathic Pulmonary FibrosisCompletedNCT02632123
- Exhaled Breath Condensate Biomarkers and Cough in IPFCompletedNCT02630940
- Clinical Progression of Mild to Moderate Idiopathic Pulmonary Fibrosis (IPF) Under a Therapy With Esbriet® (Pirfenidone)CompletedNCT02622477
- First Time in Human (FTIH) Study of GSK3008348 in Healthy Volunteers and Idiopathic Pulmonary Fibrosis PatientsCompletedNCT02612051Phase 1
- Hyperpolarized Xenon MRI in Cystic Fibrosis Pulmonary ExacerbationsCompletedNCT02606487
- Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary FibrosisWithdrawnNCT02603068Phase 2
- Home-Based Pulmonary Rehab for Patients With Pulmonary FibrosisCompletedNCT02600689Not applicable
- Lung Diffusing Capacity for Nitric Oxide as a Marker of Fibrotic Changes in Idiopathic Interstitial PneumoniasCompletedNCT02596841
- Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung DiseaseCompletedNCT02594839Phase 1/2
- Assessment of Peripheral Endothelial Function in Idiopathic Pulmonary FibrosisCompletedNCT02594059Not applicable
- Observational Study to Evaluate Disease Course and Outcomes in Patients Treated With Esbriet (Pirfenidone) for Idiopathic Pulmonary Fibrosis (IPF) in CanadaCompletedNCT02552849
- A Phase 2 Study to Evaluate the Safety and Tolerability of PBI-4050 in Patients With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT02538536Phase 2
- Responsiveness and MID of 4 Metre Gait Speed in Idiopathic Pulmonary FibrosisCompletedNCT02530736
- 68Ga-NOTA-PRGD2 PET/CT in Patients With Lung Injury and Pulmonary FibrosisStatus unknownNCT02511197Early Phase 1
- Safety and PK Study of CC-90001 in Subjects With Pulmonary FibrosisCompletedNCT02510937Phase 1
- Pirfenidone in the Chronic Hypersensitivity Pneumonitis TreatmentStatus unknownNCT02496182Phase 2/3
- 68Ga-BMV101 PET/CT in Patients With Idiopathic Pulmonary FibrosisStatus unknownNCT02485886Early Phase 1
- Using MRI to Visualize Regional Therapy Response in Idiopathic Pulmonary FibrosisCompletedNCT02478268Phase 1
- Cyclophosphamide for Acute Exacerbation of Idiopathic Pulmonary FibrosisCompletedNCT02460588Phase 3
- Reliability of the 4 Metre Gait Speed in Idiopathic Pulmonary FibrosisCompletedNCT02445157
- Genetics of the Combined Pulmonary Fibrosis and Emphysema SyndromeCompletedNCT02439528Not applicable
- Breath Analysis in Lung FibrosisCompletedNCT02437448
- The Predictive Ability of 4MGS in IPFCompletedNCT02436278
- A Longitudinal Study of Hermansky-Pudlak Syndrome Pulmonary FibrosisCompletedNCT02368340
- Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary FibrosisCompletedNCT02315586
- Effects of an Oxymizer® During Daytime in Patients With Pulmonary Fibrosis (IPF)CompletedNCT02268981Not applicable
- 3 Part Study to Assess Inhaled Nitric Oxide on Functional Pulmonary Imaging in Subj. Pulmonary Hypertension Associated w/ COPD and IPFCompletedNCT02267655Phase 1
- Auto-titrating Oxygen in Chronic Respiratory FailureCompletedNCT02248064Not applicable
- Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary FibrosisNo longer availableNCT02230982
- Biomarkers of Iron Homeostasis and Responses to Cystic Fibrosis Pulmonary Exacerbation (CFPE) TreatmentCompletedNCT02188758
- Determining in Vitro Properties of Epithelial Cells From Individuals With Genetic Variants Associated With Idiopathic Pulmonary FibrosisWithdrawnNCT02187393
- Modelling of Quality Life, Clinical and Physiological Measures in Idiopathic Pulmonary FibrosisStatus unknownNCT02176707
- Azithromycin in Idiopathic Pulmonary FibrosisCompletedNCT02173145Not applicable
- Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP)Approved for marketingNCT02171156
- A Study of Oral Vismodegib for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)WithdrawnNCT02168530Phase 2
- Prospective Evaluation of Biomarker Profiles in Idiopathic Pulmonary FibrosisCompletedNCT02151435
- Clinical Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary FibrosisCompletedNCT02136992Phase 2
- The Role of Gastroesophageal Reflux in Scleroderma Pulmonary FibrosisStatus unknownNCT02136394
- Evaluate Safety and Efficacy of Intravenous Autologous ADMSc for Treatment of Idiopathic Pulmonary FibrosisStatus unknownNCT02135380Phase 1/2
- Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CFCompletedNCT02109822
- Pilot Trial Of Omeprazole in Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT02085018Phase 2
- Inhalation Profiling of Idiopathic Pulmonary Fibrosis (IPF) PatientsCompletedNCT02058602Phase 1
- Nandrolone Decanoate in the Treatment of TelomeropathiesCompletedNCT02055456Phase 1/2
- Clinical Outcomes and Molecular Phenotypes in Smokers With Parenchymal Lung DiseaseCompletedNCT02055222
- A Validation and Dosimetry Study of GSK2634673F PET LigandTerminatedNCT02052297Phase 1
- Effect of Fostair® on Biomarkers of Platelet Adhesion in Idiopathic Pulmonary FibrosisCompletedNCT02048644Phase 2
- Allogeneic Human Cells (hMSC)in Patients With Idiopathic Pulmonary Fibrosis Via Intravenous Delivery (AETHER)TerminatedNCT02013700Phase 1
- The Effect of Pirfenidone on Cough in Patients With Idiopathic Pulmonary FibrosisCompletedNCT02009293
- Viral Pathogenesis of Early Cystic Fibrosis Lung DiseaseCompletedNCT01973192
- Pulmonary Fibrosis Contact RegistryCompletedNCT01935726
- Study of Autologous Mesenchymal Stem Cells to Treat Idiopathic Pulmonary FibrosisCompletedNCT01919827Phase 1
- Autologous CD117+ Progenitor Cell Mobilization for Lung TransplantationCompletedNCT01916577Phase 1
- Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With IPFCompletedNCT01874223
- Cromolyn Detection of Silent AspirationTerminatedNCT01841307Phase 1
- Assessment of Pulmonary Specialty Physicians' Approach to Advanced Care Planning in Patients With Chronic Pulmonary DiseasesCompletedNCT01825538
- Study of Default Options in Advance DirectivesCompletedNCT01817686Not applicable
- The Role of Rheumatological Evaluation in the Management of Patients With Interstitial Lung DiseaseStatus unknownNCT01809574
- Biomarkers of Injury and Destruction in the Cystic Fibrosis LungCompletedNCT01805713
- Study to Test the Validity of the Treatment of Idiopathic Pulmonary Fibrosis With CotrimoxazoleTerminatedNCT01777737Phase 3
- Conducting Airways in Lung Fibrosis (VACFI)CompletedNCT01777373
- Long Term Effects of an Inpatient Pulmonary Rehabilitation Program in Patients With Pulmonary FibrosisCompletedNCT01772667Not applicable
- Rituximab in Systemic SclerosisCompletedNCT01748084Phase 2/3
- Does CBT Improve the Perception/Impact of Cough and Breathlessness in IPF PatientsStatus unknownNCT01738711Not applicable
- A Proof of Mechanism Study With GSK2126458 in Patients With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT01725139Phase 1
- Biomarker Discovery for Novel Drug Development in Idiopathic Pulmonary FibrosisCompletedNCT01718990
- The Role of Gastric Content Microaspirations in the Pathogenesis of Idiopathic Pulmonary FibrosisStatus unknownNCT01714934
- Investigating Significant Health Trends in Idiopathic Pulmonary FibrosisCompletedNCT01695408
- Explorative Study on the Molecular Pathology of Lung Fibrosis by Combination of Clinical Assessment and System BiologyCompletedNCT01687946
- Comparative Study of 3 Portable Oxygen Concentrators During a 6-minute Walk Test in Patients With Chronic Lung DiseaseCompletedNCT01653730Not applicable
- CPAP Therapy in Patients With Idiopathic Pulmonary Fibrosis and Sleep ApneaCompletedNCT01637831Not applicable
- Preventive Inhalation of Hypertonic Saline in Infants With Cystic FibrosisCompletedNCT01619657Phase 2
- Cyclophosphamide Systemic Sclerosis Associated Interstitial Lung DiseaseCompletedNCT01570764Phase 3
- To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT01529853Phase 1/2
- A MultiCenter Study of Combined PEX, Rituximab, and Steroids in Acute Idiopathic Pulmonary Fibrosis ExacerbationsWithdrawnNCT01524068Phase 2
- Safety and Efficacy Study of Pirfenidone to Treat Idiopathic Pulmonary Fibrosis(IPF)Status unknownNCT01504334Phase 2
- Pulmonary Fibrosis and Telomerase Mutation StudyCompletedNCT01501578